These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19074869)

  • 1. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study.
    Balan V; Nangia-Makker P; Schwartz AG; Jung YS; Tait L; Hogan V; Raz T; Wang Y; Yang ZQ; Wu GS; Guo Y; Li H; Abrams J; Couch FJ; Lingle WL; Lloyd RV; Ethier SP; Tainsky MA; Raz A
    Cancer Res; 2008 Dec; 68(24):10045-50. PubMed ID: 19074869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer.
    Nangia-Makker P; Wang Y; Raz T; Tait L; Balan V; Hogan V; Raz A
    Int J Cancer; 2010 Dec; 127(11):2530-41. PubMed ID: 20162566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells.
    Mazurek N; Byrd JC; Sun Y; Ueno S; Bresalier RS
    Cancer; 2011 Oct; 117(19):4375-80. PubMed ID: 21446041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.
    Corrado A; Aceto R; Silvestri R; Dell'Anno I; Ricci B; Miglietta S; Romei C; Giovannoni R; Poliseno L; Evangelista M; Vitiello M; Cipollini M; Garritano S; Giusti L; Zallocco L; Elisei R; Landi S; Gemignani F
    Thyroid; 2021 Jul; 31(7):1056-1066. PubMed ID: 33308024
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine.
    Shi Y; Steppi A; Cao Y; Wang J; He MM; Li L; Zhang J
    Cancer Res; 2017 Jan; 77(2):423-433. PubMed ID: 28069798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts.
    Bell DW; Kim SH; Godwin AK; Schiripo TA; Harris PL; Haserlat SM; Wahrer DC; Haiman CA; Daly MB; Niendorf KB; Smith MR; Sgroi DC; Garber JE; Olopade OI; Le Marchand L; Henderson BE; Altshuler D; Haber DA; Freedman ML
    Int J Cancer; 2007 Dec; 121(12):2661-7. PubMed ID: 17721994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor Recurrence.
    Keenan T; Moy B; Mroz EA; Ross K; Niemierko A; Rocco JW; Isakoff S; Ellisen LW; Bardia A
    J Clin Oncol; 2015 Nov; 33(31):3621-7. PubMed ID: 26371147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-catenin in gastric cancer.
    Kim SJ; Shin JY; Cheong TC; Choi IJ; Lee YS; Park SH; Chun KH
    Clin Exp Metastasis; 2011 Dec; 28(8):743-50. PubMed ID: 21750908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population.
    Belyavskaya VA; Prudnikova TY; Domanitskaya NV; Litviakov NV; Maksimov VN; Cherdyntseva NV; Grigorieva EV
    Gene; 2017 Sep; 628():224-229. PubMed ID: 28734894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.
    de Bruin MA; Kwong A; Goldstein BA; Lipson JA; Ikeda DM; McPherson L; Sharma B; Kardashian A; Schackmann E; Kingham KE; Mills MA; West DW; Ford JM; Kurian AW
    Fam Cancer; 2012 Sep; 11(3):429-39. PubMed ID: 22638769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection.
    Huang WC; Chen HL; Chen HY; Peng KP; Lee Y; Huang LM; Chang LY; Liu FT
    PLoS One; 2016; 11(12):e0168627. PubMed ID: 28002441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case-control studies.
    Qi X; Zhang F; Yang X; Fan L; Zhang Y; Chen L; Zhou Y; Chen X; Zhong L; Jiang J
    Breast Cancer Res Treat; 2010 Jul; 122(1):273-9. PubMed ID: 20309626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline BRCA1 mutations and G/C polymorphism in the 5'-untranslated region of the RAD51 gene in Polish women with breast cancer.
    Romanowicz-Makowska H; Smolarz B; Kulig A
    Pol J Pathol; 2005; 56(4):161-5. PubMed ID: 16477874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer.
    Martin SE; Sausen M; Joseph A; Biggs DD; Kingham BF; Martin ES
    Breast Cancer Res Treat; 2009 Jan; 113(2):393-5. PubMed ID: 18311584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.
    Cao AY; Jin W; Shi PC; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2010 Jan; 119(2):295-303. PubMed ID: 19238535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline BRCA1 mutations in Iranian women with breast cancer.
    Ghaderi A; Talei A; Farjadian S; Mosalaei A; Doroudchi M; Kimura H
    Cancer Lett; 2001 Apr; 165(1):87-94. PubMed ID: 11248423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline RAP80 mutations and susceptibility to breast cancer.
    Akbari MR; Ghadirian P; Robidoux A; Foumani M; Sun Y; Royer R; Zandvakili I; Lynch H; Narod SA
    Breast Cancer Res Treat; 2009 Jan; 113(2):377-81. PubMed ID: 18306035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry.
    Quan L; Gong Z; Yao S; Bandera EV; Zirpoli G; Hwang H; Roberts M; Ciupak G; Davis W; Sucheston L; Pawlish K; Bovbjerg DH; Jandorf L; Cabasag C; Coignet JG; Ambrosone CB; Hong CC
    Int J Cancer; 2014 Mar; 134(6):1408-21. PubMed ID: 23996684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.